title: Memantine discontinuation and the health status of nursing home residents with Alzheimer's disease.
authors.affiliation: Brookdale Department of Geriatrics and Adult Development, The Mount Sinai School of Medicine, New York, NY, USA. hfillit@alzdiscovery.org
authors.forename: Howard
authors.initials: H
authors.lastname: Fillit
authors.forename: Robert K
authors.initials: RK
authors.lastname: Hofbauer
authors.forename: Juliana
authors.initials: J
authors.lastname: Setyawan
authors.forename: Stavros
authors.initials: S
authors.lastname: Tourkodimitris
authors.forename: Moshe
authors.initials: M
authors.lastname: Fridman
authors.forename: Vojislav
authors.initials: V
authors.lastname: Pejović
authors.forename: Michael L
authors.initials: ML
authors.lastname: Miller
authors.forename: M Haim
authors.initials: MH
authors.lastname: Erder
authors.forename: Constantine
authors.initials: C
authors.lastname: Lyketsos
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D006304:Health Status; D006801:Humans; D008485:Medical Audit; D008559:Memantine / Q000627:therapeutic use*; D009735:Nursing Homes; D012189:Retrospective Studies; D014481:United States; D028761:Withholding Treatment
chemical_list: D000978:Antiparkinson Agents; D008559:Memantine